血友病治療薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Hemophilia Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST05283 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、血友病治療薬の世界市場について調査・分析し、血友病治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（血友病A、血友病B、血友病C）、用途別（病院、診療所、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の血友病治療薬市場動向 ・主要企業別マーケットシェア ・血友病治療薬の種類別市場規模2014-2019 （血友病A、血友病B、血友病C） ・血友病治療薬の用途別市場規模2014-2019 （病院、診療所、外来手術センター） ・血友病治療薬の北米市場：主要企業・種類別/用途別市場規模 ・血友病治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・血友病治療薬の中国市場：主要企業・種類別/用途別市場規模 ・血友病治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・血友病治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・血友病治療薬のインド市場：主要企業・種類別/用途別市場規模 ・血友病治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bayer AG、Pfizer, Inc.、Novo Nordisk A/S、Baxter International Inc.、Biogen Idec, Inc.、Genetics Institute、Alpha Therapeutics Corporation、Expression Therapeutics、Swedish Orphan Biovitrum AB.） ・血友病治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a protein required for blood clotting to occur normally. These proteins work with platelets i.e. small blood cell fragments that form in the bone marrow, to help the blood clot. Hemophilia is passed from parents to children through genes. In 2018, the global Hemophilia Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hemophilia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemophilia Therapeutics development in United States, Europe and China.

The key players covered in this study
Bayer AG
Pfizer, Inc.
Novo Nordisk A/S
Baxter International Inc.
Biogen Idec, Inc.
Genetics Institute
Alpha Therapeutics Corporation
Expression Therapeutics
Swedish Orphan Biovitrum AB.

Market segment by Type, the product can be split into
hemophilia A
hemophilia B
hemophilia C

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers 

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hemophilia Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Hemophilia Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hemophilia Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hemophilia Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 hemophilia A
1.4.3 hemophilia B
1.4.4 hemophilia C
1.5 Market by Application
1.5.1 Global Hemophilia Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers 
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hemophilia Therapeutics Market Size
2.2 Hemophilia Therapeutics Growth Trends by Regions
2.2.1 Hemophilia Therapeutics Market Size by Regions (2014-2025)
2.2.2 Hemophilia Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hemophilia Therapeutics Market Size by Manufacturers
3.1.1 Global Hemophilia Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Hemophilia Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hemophilia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Hemophilia Therapeutics Key Players Head office and Area Served
3.3 Key Players Hemophilia Therapeutics Product/Solution/Service
3.4 Date of Enter into Hemophilia Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hemophilia Therapeutics Market Size by Type (2014-2019)
4.2 Global Hemophilia Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Hemophilia Therapeutics Market Size (2014-2019)
5.2 Hemophilia Therapeutics Key Players in United States
5.3 United States Hemophilia Therapeutics Market Size by Type
5.4 United States Hemophilia Therapeutics Market Size by Application

6 Europe
6.1 Europe Hemophilia Therapeutics Market Size (2014-2019)
6.2 Hemophilia Therapeutics Key Players in Europe
6.3 Europe Hemophilia Therapeutics Market Size by Type
6.4 Europe Hemophilia Therapeutics Market Size by Application

7 China
7.1 China Hemophilia Therapeutics Market Size (2014-2019)
7.2 Hemophilia Therapeutics Key Players in China
7.3 China Hemophilia Therapeutics Market Size by Type
7.4 China Hemophilia Therapeutics Market Size by Application

8 Japan
8.1 Japan Hemophilia Therapeutics Market Size (2014-2019)
8.2 Hemophilia Therapeutics Key Players in Japan
8.3 Japan Hemophilia Therapeutics Market Size by Type
8.4 Japan Hemophilia Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hemophilia Therapeutics Market Size (2014-2019)
9.2 Hemophilia Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Hemophilia Therapeutics Market Size by Type
9.4 Southeast Asia Hemophilia Therapeutics Market Size by Application

10 India
10.1 India Hemophilia Therapeutics Market Size (2014-2019)
10.2 Hemophilia Therapeutics Key Players in India
10.3 India Hemophilia Therapeutics Market Size by Type
10.4 India Hemophilia Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Hemophilia Therapeutics Market Size (2014-2019)
11.2 Hemophilia Therapeutics Key Players in Central & South America
11.3 Central & South America Hemophilia Therapeutics Market Size by Type
11.4 Central & South America Hemophilia Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bayer AG
12.1.1 Bayer AG Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hemophilia Therapeutics Introduction
12.1.4 Bayer AG Revenue in Hemophilia Therapeutics Business (2014-2019)
12.1.5 Bayer AG Recent Development
12.2 Pfizer, Inc.
12.2.1 Pfizer, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hemophilia Therapeutics Introduction
12.2.4 Pfizer, Inc. Revenue in Hemophilia Therapeutics Business (2014-2019)
12.2.5 Pfizer, Inc. Recent Development
12.3 Novo Nordisk A/S
12.3.1 Novo Nordisk A/S Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hemophilia Therapeutics Introduction
12.3.4 Novo Nordisk A/S Revenue in Hemophilia Therapeutics Business (2014-2019)
12.3.5 Novo Nordisk A/S Recent Development
12.4 Baxter International Inc.
12.4.1 Baxter International Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hemophilia Therapeutics Introduction
12.4.4 Baxter International Inc. Revenue in Hemophilia Therapeutics Business (2014-2019)
12.4.5 Baxter International Inc. Recent Development
12.5 Biogen Idec, Inc.
12.5.1 Biogen Idec, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hemophilia Therapeutics Introduction
12.5.4 Biogen Idec, Inc. Revenue in Hemophilia Therapeutics Business (2014-2019)
12.5.5 Biogen Idec, Inc. Recent Development
12.6 Genetics Institute
12.6.1 Genetics Institute Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hemophilia Therapeutics Introduction
12.6.4 Genetics Institute Revenue in Hemophilia Therapeutics Business (2014-2019)
12.6.5 Genetics Institute Recent Development
12.7 Alpha Therapeutics Corporation
12.7.1 Alpha Therapeutics Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hemophilia Therapeutics Introduction
12.7.4 Alpha Therapeutics Corporation Revenue in Hemophilia Therapeutics Business (2014-2019)
12.7.5 Alpha Therapeutics Corporation Recent Development
12.8 Expression Therapeutics
12.8.1 Expression Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hemophilia Therapeutics Introduction
12.8.4 Expression Therapeutics Revenue in Hemophilia Therapeutics Business (2014-2019)
12.8.5 Expression Therapeutics Recent Development
12.9 Swedish Orphan Biovitrum AB.
12.9.1 Swedish Orphan Biovitrum AB. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hemophilia Therapeutics Introduction
12.9.4 Swedish Orphan Biovitrum AB. Revenue in Hemophilia Therapeutics Business (2014-2019)
12.9.5 Swedish Orphan Biovitrum AB. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Hemophilia Therapeutics Key Market Segments
Table Key Players Hemophilia Therapeutics Covered
Table Global Hemophilia Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hemophilia Therapeutics Market Size Market Share by Type 2014-2025
Figure hemophilia A Figures
Table Key Players of hemophilia A
Figure hemophilia B Figures
Table Key Players of hemophilia B
Figure hemophilia C Figures
Table Key Players of hemophilia C
Table Global Hemophilia Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers  Case Studies
Figure Hemophilia Therapeutics Report Years Considered
Table Global Hemophilia Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Hemophilia Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hemophilia Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Hemophilia Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Hemophilia Therapeutics Market Share by Regions 2014-2019
Figure Global Hemophilia Therapeutics Market Share by Regions 2014-2019
Figure Global Hemophilia Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Hemophilia Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hemophilia Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Hemophilia Therapeutics Market Share by Manufacturers in 2018
Table Global Hemophilia Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hemophilia Therapeutics Product/Solution/Service
Table Date of Enter into Hemophilia Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hemophilia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Hemophilia Therapeutics Market Size Share by Type (2014-2019)
Figure Global Hemophilia Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Hemophilia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Hemophilia Therapeutics Market Size Share by Application (2014-2019)
Figure Global Hemophilia Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Hemophilia Therapeutics Revenue Market Share by Application in 2018
Figure United States Hemophilia Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Hemophilia Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Hemophilia Therapeutics Market Share (2018-2019)
Table United States Hemophilia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Hemophilia Therapeutics Market Share by Type (2014-2019)
Table United States Hemophilia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Hemophilia Therapeutics Market Share by Application (2014-2019)
Figure Europe Hemophilia Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Hemophilia Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Hemophilia Therapeutics Market Share (2018-2019)
Table Europe Hemophilia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Hemophilia Therapeutics Market Share by Type (2014-2019)
Table Europe Hemophilia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Hemophilia Therapeutics Market Share by Application (2014-2019)
Figure China Hemophilia Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Hemophilia Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Hemophilia Therapeutics Market Share (2018-2019)
Table China Hemophilia Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Hemophilia Therapeutics Market Share by Type (2014-2019)
Table China Hemophilia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Hemophilia Therapeutics Market Share by Application (2014-2019)
Figure Japan Hemophilia Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Hemophilia Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Hemophilia Therapeutics Market Share (2018-2019)
Table Japan Hemophilia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Hemophilia Therapeutics Market Share by Type (2014-2019)
Table Japan Hemophilia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Hemophilia Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Hemophilia Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hemophilia Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hemophilia Therapeutics Market Share (2018-2019)
Table Southeast Asia Hemophilia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hemophilia Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Hemophilia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hemophilia Therapeutics Market Share by Application (2014-2019)
Figure India Hemophilia Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Hemophilia Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Hemophilia Therapeutics Market Share (2018-2019)
Table India Hemophilia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Hemophilia Therapeutics Market Share by Type (2014-2019)
Table India Hemophilia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Hemophilia Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Hemophilia Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hemophilia Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hemophilia Therapeutics Market Share (2018-2019)
Table Central & South America Hemophilia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hemophilia Therapeutics Market Share by Type (2014-2019)
Table Central & South America Hemophilia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hemophilia Therapeutics Market Share by Application (2014-2019)
Table Bayer AG Company Details
Table Bayer AG Revenue in Hemophilia Therapeutics Business (2014-2019) (Million US$)
Figure Bayer AG Revenue Growth Rate in Hemophilia Therapeutics Business (2014-2019)
Table Bayer AG Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Hemophilia Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Hemophilia Therapeutics Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table Novo Nordisk A/S Company Details
Table Novo Nordisk A/S Revenue in Hemophilia Therapeutics Business (2014-2019)(Million US$)
Figure Novo Nordisk A/S Revenue Growth Rate in Hemophilia Therapeutics Business (2014-2019)
Table Novo Nordisk A/S Recent Development
Table Baxter International Inc. Company Details
Table Baxter International Inc. Revenue in Hemophilia Therapeutics Business (2014-2019)(Million US$)
Figure Baxter International Inc. Revenue Growth Rate in Hemophilia Therapeutics Business (2014-2019)
Table Baxter International Inc. Recent Development
Table Biogen Idec, Inc. Company Details
Table Biogen Idec, Inc. Revenue in Hemophilia Therapeutics Business (2014-2019)(Million US$)
Figure Biogen Idec, Inc. Revenue Growth Rate in Hemophilia Therapeutics Business (2014-2019)
Table Biogen Idec, Inc. Recent Development
Table Genetics Institute Company Details
Table Genetics Institute Revenue in Hemophilia Therapeutics Business (2014-2019)(Million US$)
Figure Genetics Institute Revenue Growth Rate in Hemophilia Therapeutics Business (2014-2019)
Table Genetics Institute Recent Development
Table Alpha Therapeutics Corporation Company Details
Table Alpha Therapeutics Corporation Revenue in Hemophilia Therapeutics Business (2014-2019)(Million US$)
Figure Alpha Therapeutics Corporation Revenue Growth Rate in Hemophilia Therapeutics Business (2014-2019)
Table Alpha Therapeutics Corporation Recent Development
Table Expression Therapeutics Company Details
Table Expression Therapeutics Revenue in Hemophilia Therapeutics Business (2014-2019)(Million US$)
Figure Expression Therapeutics Revenue Growth Rate in Hemophilia Therapeutics Business (2014-2019)
Table Expression Therapeutics Recent Development
Table Swedish Orphan Biovitrum AB. Company Details
Table Swedish Orphan Biovitrum AB. Revenue in Hemophilia Therapeutics Business (2014-2019)(Million US$)
Figure Swedish Orphan Biovitrum AB. Revenue Growth Rate in Hemophilia Therapeutics Business (2014-2019)
Table Swedish Orphan Biovitrum AB. Recent Development
Table Global Hemophilia Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Hemophilia Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Hemophilia Therapeutics Market Size Share by Regions in 2025
Figure United States Hemophilia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hemophilia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Hemophilia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hemophilia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hemophilia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Hemophilia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hemophilia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Hemophilia Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Hemophilia Therapeutics Market Size by Product (2019-2025)
Figure Global Hemophilia Therapeutics Market Size by Product in 2025
Table Global Hemophilia Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Hemophilia Therapeutics Market Size by Application (2019-2025)
Figure Global Hemophilia Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---